1.
Halabi S,
Kelly WK,
Ma H, и др.Meta-analysis evaluating the impact of site of metastasis on overall survival in men with castration-resistant prostate cancer. J Clin Oncol2016;34:1652–9.
doi:10.1200/JCO.2015.65.7270
2.
Cook GJR,
Azad G,
Padhani AR.
Bone imaging in prostate cancer: the evolving roles of nuclear medicine and radiology.
Clin.
Transl.
Imaging.
2016;4:439–47.
doi:10.1007/s40336-016-0196-5
3.
James ND,
Spears MR,
Clarke NW, и др.Survival with newly diagnosed metastatic prostate cancer in the docetaxel era: Data from 917 patients in the control arm of the STAMPEDE Trial (MRC PR08,
CRUK/06/019). Eur Urol2015;67:1028–38.
doi:10.1016/j.eururo.2014.09.032
4.
van den Bergh RCN,
Loeb S,
Roobol MJ.
Impact of Early Diagnosis of Prostate Cancer on Survival Outcomes.
Eur.
Urol.
Focus.
2015;1:137–46.
doi:10.1016/j.euf.2015.01.002
5.
Pyka T,
Okamoto S,
Dahlbender M, и др.Comparison of bone scintigraphy and 68Ga-PSMA PET for skeletal staging in prostate cancer. Eur J Nucl Med Mol Imaging2016;43:2114–21.
doi:10.1007/s00259-016-3435-0
6.
Stecco a,
Romano G,
Negru M, и др.Whole-body diffusion-weighted magnetic resonance imaging in the staging of oncological patients: comparison with positron emission tomography computed tomography (PET-CT) in a pilot study. Radiol Med2009;114:1–17.
doi:10.1007/s11547-008-0348-4
7.
Li S,
Sun F,
Jin ZY, и др.Whole-body diffusion-weighted imaging: Technical improvement and preliminary results. J Magn Reson Imaging2007;26:1139–44.
doi:10.1002/jmri.21074
8.
Daldrup-Link HE,
Henning T,
Link TM.
MR imaging of therapy-induced changes of bone marrow.
Eur.
Radiol.
2007;17:743–61.
doi:10.1007/s00330-006-0404-1